Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2026-03-26 @ 3:15 PM
Ignite Modification Date:
2026-03-26 @ 3:15 PM
NCT ID:
NCT07341659
Eligibility Criteria:
Inclusion Criteria:
* Male or Female aged between 15 and 35 years included
* Subject affiliated to a social security system or health insurance, or is a beneficiary if applicable
* Subject who recently completed his/her first course of oral isotretinoin treatment
* Subject with clear or almost clear facial acne
Non Inclusion criteria:
* Subject who, in the judgement of the investigator, is not likely to be compliant with study-related constraints and requirements
* Facial skin disease other than acne, skin abnormalities, or dermatological condition on the face liable to interfere with the study assessments
* Severe or complicated cases of acne (ex: acne conglobate) according to investigator's assessment
* Any acute, chronic or progressive disease or medical history liable to interfere with the study data or considered by the Investigator hazardous for the subject or incompatible with the study requirements
* Any surgery, chemical (e.g.: skin peel) or physical treatment on the face done within 12 months before the inclusion or planned during the study
* Topical or systemic product or treatment established or modified during the previous weeks or planned to be established or modified during the study, liable to interfere with the evaluation of the efficacy or cutaneous tolerance of the investigational product according to the investigator's assessment
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
15 Years
Maximum Age:
35 Years
Study:
NCT07341659
Study Brief:
Protocol Section:
NCT07341659